Advertisement
Advertisement

MGTX

MGTX logo

MeiraGTx Holdings plc

6.34
USD
-0.06
-0.94%
Dec 18, 12:33 UTC -5
Open

MeiraGTx Holdings plc Profile

About

MeiraGTx Holdings plc focuses on operating as a holding company for MeiraGTx Limited which operates as a clinical stage gene therapy company. It develops novel gene therapy treatments for inherited and acquired disorders. The company's product pipeline consists of AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, AAV-AQP1 and AAV-UPF1 which are in clinical stage. MeiraGTx Holdings plc is based in New York.

Info & Links

CEO

Alexandria Forbes

Headquarters

450 East 29th Street, 14th Floor
NEW YORK, NY 10016, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

52

Employees

425

MeiraGTx Holdings plc Statistics

Valuation Measures

Market Capitalization2

495.47M

Enterprise Value

459.33M

Enterprise Value/EBITDA(ttm)

-2.84

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

34.34

Price to Book(mrq)

5.00

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

72.54%

Operating Margin(ttm)

-1144.63%

Profit Margin(ttm)

-4885.89%

Return on Equity(ttm)

-146.38%

Return on Invested Capital(ttm)

-52.69%

Return on Assets(ttm)

-53.05%

Income Statement

Revenue(ttm)

13.93M

Revenue Per Share(ttm)

0.18

Gross Profit(ttm)

1.94M

EBITDA(ttm)3

-161.52M

Net Income Available to Common(ttm)

-88.18M

Diluted EPS(ttm)

-1.21

Share Statistics

Beta (5Y Monthly)

1.25

52-Week Change

21.46%

S&P 500 52-Week Change

28.02%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

78.15M

Dividend Yield

0.00%

Float4

71.59M

% Held by Insiders

8.40%

% Held by Institutions

67.48%

Balance Sheet

Total Cash(mrq)

122.87M

Total Cash Per Share(mrq)

1.57

Total Debt(mrq)

86.73M

Total Debt/Equity(mrq)

90.60%

Current Ratio(mrq)

2.34%

Quick Ratio(mrq)

2.34%

Book Value Per Share(mrq)

1.23

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.13

Free Cash Flow(ytd)

-84.96M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement